I know today is rough. To be quite frank, I was considering selling on the open - it's tough to watch money drain from my account. But, I know the market is irrational and unfortunately this is the game we play.
Now, this isn't over. The results can't be better in OZ compared to the USA. There is a reason for this. I can sense the market knows that, especially those that understand what we have in hand. We just completed a Ph2 trial with SIGNIFICANT results, but an error in one data set....
CBD manufacturing differences is a huge *$%# upon management's behalf, or maybe it wasn't on them. I would be surprised if they didn't rectify this before the AGM.
Also, there is a lot of good in the company. We have 3 products in the pipeline, and our Ph2 pulled through with positives. I can not justify this MC given the development we have made since Phase 1b results across the board.
This isn't a gameover result. Look at $RAP for some confidence.....
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1503 Acne Phase 2 Study Results Presentation
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-67
-
- There are more pages in this discussion • 584 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 13012 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 0.385 |
5 | 21250 | 0.380 |
1 | 40 | 0.375 |
2 | 16983 | 0.370 |
4 | 466054 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 444 | 1 |
0.375 | 27500 | 2 |
0.380 | 290841 | 15 |
0.385 | 220411 | 9 |
0.390 | 815895 | 13 |
Last trade - 09.41am 16/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online